SUVRETTA CAPITAL MANAGEMENT, LLC purchased 5.2% of their position (47.52K shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $527.2K — a moderate purchase. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 12/26/2024ACC: 0000899140-24-001385
10% Owner
Since Apr 2024
+47.52K
Net shares
Net buyer
$527.2K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
47.52K acquired
Non-Derivative Transactions4
Common stock, par value $0.0001 per share
Indirect
Shares
+24.36K
Price / share
$10.98
Trade value
$267.47K
% of position
0.3%
12/23/2024
7.96M→7.98M
Common stock, par value $0.0001 per share
Indirect
Shares
+3.14K
Price / share
$10.98
Trade value
$34.50K
% of position
0.3%
12/23/2024
955.12K→958.27K
Common stock, par value $0.0001 per share
Indirect
Shares
+17.73K
Price / share
$11.25
Trade value
$199.46K
% of position
0.2%
12/24/2024
7.98M→8M
Common stock, par value $0.0001 per share
Indirect
Shares
+2.29K
Price / share
$11.25
Trade value
$25.74K
% of position
0.2%
12/24/2024
958.27K→960.55K
Total
Net shares
+47.52K
Net value
$527.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 12/23/2024 | P · Purchase | +24.36K | $10.98 | $267.47K | 0.3% | 7.96M | 7.98M |
| Common stock, par value $0.0001 per share Indirect | 12/23/2024 | P · Purchase | +3.14K | $10.98 | $34.50K | 0.3% | 955.12K | 958.27K |
| Common stock, par value $0.0001 per share Indirect | 12/24/2024 | P · Purchase | +17.73K | $11.25 | $199.46K | 0.2% | 7.98M | 8M |
| Common stock, par value $0.0001 per share Indirect | 12/24/2024 | P · Purchase | +2.29K | $11.25 | $25.74K | 0.2% | 958.27K | 960.55K |
| Total | +47.52K | $527.17K | ||||||
Derivative Transactions0
No derivative transactions reported